{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:39:29Z","timestamp":1791218369539,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Canada COVID-19 Immunity Task Force, Public Health Agency of Canada","award":["2122-HQ-000073"],"award-info":[{"award-number":["2122-HQ-000073"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-026-02021-1","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T16:05:59Z","timestamp":1777133159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity"],"prefix":"10.1007","volume":"46","author":[{"given":"Luana L. T. N.","family":"Porto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Yazji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Unninayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Decaluwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Derfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Issekutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kalashnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Murgu\u00eda-Favela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Upton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A. M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Chapdelaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia Liana","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Oldford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andre","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthaporn","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VISID study investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne C.","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystyna","family":"Kalincinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Touzot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Lacuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Betschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"2021_CR1","unstructured":"UNICEF. Child mortality and COVID-19. 2024."},{"key":"2021_CR2","doi-asserted-by":"crossref","unstructured":"Lindahl H, Kahn F, Nilsdotter-Augustinsson \u00c5\u00c5, et al. Inborn errors of immunity are associated with increased COVID-19-related hospitalization and intensive care compared to the general population. J Allergy Clin Immunol. 2024. Available at: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0091674924011254","DOI":"10.1016\/j.jaci.2024.10.013"},{"key":"2021_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","volume":"147","author":"AM Shields","year":"2021","unstructured":"Shields AM, Burns SO, Savic S, et al. COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. J Allergy Clin Immunol. 2021;147:870\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"2021_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s10875-022-01296-4","volume":"42","author":"JJ Shin","year":"2022","unstructured":"Shin JJ, Par-Young J, Unlu S, et al. Defining clinical and immunological predictors of poor immune responses to COVID-19 mRNA vaccines in patients with primary antibody deficiency. J Clin Immunol. 2022;42:1137\u201350.","journal-title":"J Clin Immunol"},{"key":"2021_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.anai.2013.05.033","volume":"111","author":"M Ballow","year":"2013","unstructured":"Ballow M. Use of vaccines in the evaluation of presumed immunodeficiency. Annals of Allergy, Asthma & Immunology. 2013;111:163\u20136. https:\/\/doi.org\/10.1016\/j.anai.2013.05.033.","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"2021_CR6","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1016\/j.jaip.2023.07.042","volume":"11","author":"AA Nguyen","year":"2023","unstructured":"Nguyen AA, Habiballah SB, LaBere B, et al. Rethinking immunological risk: a retrospective cohort study of severe SARS-Cov-2 infections in individuals with congenital immuno deficiencies. J Allergy Clin Immunol Pract. 2023;11:3391\u20139.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s10875-023-01613-5","volume":"44","author":"J McDonnell","year":"2024","unstructured":"McDonnell J, Cousins K, Younger MEM, et al. COVID-19 vaccination in patients with inborn errors of immunity reduces hospitalization and critical care needs related to COVID-19: a USIDNET report. J Clin Immunol. 2024;44:86.","journal-title":"J Clin Immunol"},{"key":"2021_CR8","unstructured":"Archive 22: Recommendations on the use of COVID-19 vaccines [2021-10-22] - Canada.ca. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/national-advisory-committee-on-immunization-naci\/recommendations-use-covid-19-vaccines.html. Accessed 27 July 2025."},{"key":"2021_CR9","unstructured":"COVID-19 vaccines: Canadian Immunization Guide - Canada.ca. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-26-covid-19-vaccine.html. Accessed 27 July 2025."},{"key":"2021_CR10","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jaip.2022.03.017","volume":"10","author":"S Barmettler","year":"2022","unstructured":"Barmettler S, DiGiacomo DV, Yang NJ, et al. Response to severe acute respiratory syndrome coronavirus 2 initial series andadditional dose vaccine in patients with predominant antibody deficiency. J Allergy Clin Immunol Pract. 2022;10:1622\u201334.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2021_CR11","doi-asserted-by":"publisher","first-page":"1217718","DOI":"10.3389\/fimmu.2023.1217718","volume":"14","author":"M Tandon","year":"2023","unstructured":"Tandon M, DiGiacomo DV, Zhou B, et al. Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency. Front Immunol. 2023;14:1217718.","journal-title":"Front Immunol"},{"key":"2021_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.982155","volume":"13","author":"D Leung","year":"2022","unstructured":"Leung D, Mu X, Duque JSR, et al. Safety and immunogenicity of 3 doses ofBNT162b2 and CoronaVac in children and adults with inborn errors of immunity. Front Immunol. 2022;13:982155.","journal-title":"Front Immunol"},{"key":"2021_CR13","doi-asserted-by":"publisher","first-page":"1390022","DOI":"10.3389\/fimmu.2024.1390022","volume":"15","author":"LPM van Leeuwen","year":"2024","unstructured":"van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, et al. Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program. Front Immunol. 2024;15:1390022.","journal-title":"Front Immunol"},{"key":"2021_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/vaccines11020354","volume":"11","author":"Z Lucane","year":"2023","unstructured":"Lucane Z, Slisere B, Ozola L, et al. Long-term immunological memory of SARS-CoV-2 is present in patients with primary antibody deficiencies for up to a year after vaccination. Vaccines (Basel). 2023;11:354.","journal-title":"Vaccines (Basel)"},{"key":"2021_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jinf.2021.12.003","volume":"84","author":"WA Mak","year":"2022","unstructured":"Mak WA, Koeleman JGM, van der Vliet M, Keuren F, Ong DSY. SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study. J Infect. 2022;84:171\u20138.","journal-title":"J Infect"},{"key":"2021_CR16","doi-asserted-by":"publisher","first-page":"eadh3150","DOI":"10.1126\/sciadv.adh3150","volume":"9","author":"M Zendt","year":"2023","unstructured":"Zendt M, Bustos Carrillo FA, Kelly S, et al. Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immuno deficiencies. Sci Adv. 2023;9:eadh3150.","journal-title":"Sci Adv"},{"key":"2021_CR17","doi-asserted-by":"publisher","first-page":"1501908","DOI":"10.3389\/fimmu.2024.1501908","volume":"15","author":"D Unninayar","year":"2024","unstructured":"Unninayar D, Falcone EL, Chapdelaine H, et al. Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections. Front Immunol. 2024;15:1501908.","journal-title":"Front Immunol"},{"key":"2021_CR18","doi-asserted-by":"crossref","unstructured":"Staels F, Collignon T, Betrains A, et al. Monogenic adult-onset inborn errors of immunity. Front Immunol. 2021;12. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/34867986\/. Accessed 12 Feb 2026.","DOI":"10.3389\/fimmu.2021.753978"},{"key":"2021_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1159\/000540538","volume":"185","author":"E Karabiber","year":"2024","unstructured":"Karabiber E, Baris S. Delineating the clinical and immunologic characteristics: a comparative study of inborn errors of immunity in adult versus pediatric diagnosed. Int Arch Allergy Immunol. 2024;185:1123\u201335. https:\/\/doi.org\/10.1159\/000540538.","journal-title":"Int Arch Allergy Immunol"},{"key":"2021_CR20","doi-asserted-by":"crossref","unstructured":"Bousfiha A, Jeddane L, Picard C, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol 2020;40:66\u201381. Available at: \/pmc\/articles\/PMC7082388\/. Accessed 16 Feb 2021.","DOI":"10.1007\/s10875-020-00758-x"},{"key":"2021_CR21","first-page":"53","volume-title":"Multiple sclerosis : methods and protocols","author":"C Riedhammer","year":"2016","unstructured":"Riedhammer C, Halbritter D, Weissert R. Peripheral blood mononuclear cells: isolation, freezing, thawing, and culture. In: Multiple sclerosis : methods and protocols; 2016. p. 53\u201361."},{"key":"2021_CR22","doi-asserted-by":"crossref","unstructured":"Unninayar D, Falcone EL, Chapdelaine H, et al. Humoral and cell-mediated immune responses to COVID-19 vaccines up to6 months post 3dose primary series in adults with inborn errors of immunity and their breakthrough infections. Front Immunol. 15:1501908.","DOI":"10.3389\/fimmu.2024.1501908"},{"key":"2021_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1380","volume":"11","author":"K Colwill","year":"2022","unstructured":"Colwill K, Galipeau Y, Stuible M, et al. A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. Clin Transl Immunology. 2022;11:e1380.","journal-title":"Clin Transl Immunology"},{"key":"2021_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s10875-023-01514-7","volume":"43","author":"LPM Van Leeuwen","year":"2023","unstructured":"Van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, et al. Immune responses6 months after mRNA-1273 COVID-19 vaccination and the effect of a third vaccination in patients with inborn errors of immunity. J Clin Immunol. 2023;43:1104\u201317.","journal-title":"J Clin Immunol"},{"key":"2021_CR25","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jaci.2022.04.002","volume":"149","author":"LPM van Leeuwen","year":"2022","unstructured":"van Leeuwen LPM, GeurtsvanKessel CH, Ellerbroek PM, et al. Immunogenicity of the mRNA-1273 COVID-19vaccine in adult patients with inborn errors of immunity. J Allergy Clin Immunol. 2022;149:1949\u201357.","journal-title":"J Allergy Clin Immunol"},{"key":"2021_CR26","volume":"3","author":"AM Zhang","year":"2024","unstructured":"Zhang AM, Elmoursi A, DiGiacomo DV, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency. J Allergy Clin Immunol : Glob. 2024;3:100234.","journal-title":"J Allergy Clin Immunol : Glob"},{"key":"2021_CR27","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10875-021-01133-0","volume":"41","author":"AF Salinas","year":"2021","unstructured":"Salinas AF, Mortari EP, Terreri S, et al. SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best. J Clin Immunol. 2021;41:1709\u201322.","journal-title":"J Clin Immunol"},{"key":"2021_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.anai.2021.03.005","volume":"127","author":"TK Lee","year":"2021","unstructured":"Lee TK, Gereige JD, Maglione PJ. State-of-the-art diagnostic evaluation of common variable immunodeficiency. Ann Allergy Asthma Immunol. 2021;127:19\u201327.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s11882-001-0065-8","volume":"1","author":"DM Stewart","year":"2001","unstructured":"Stewart DM, Tian L, Nelson DL. The clinical spectrum of Bruton\u2019s agammaglobulinemia. Curr AllergyAsthma Rep. 2001;1:558\u201365.","journal-title":"Curr AllergyAsthma Rep"},{"key":"2021_CR30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s10875-022-01283-9","volume":"42","author":"H Lindahl","year":"2022","unstructured":"Lindahl H, Klingstr\u00f6\u00f6m J, Da Silva Rodrigues R, et al. Neutralizing SARS-CoV-2 antibodies in commercial immunoglobulin products give patients with X-linked agammaglobulinemia limited passive immunity to the omicron variant. J Clin Immunol. 2022;42:1130\u20136.","journal-title":"J Clin Immunol"},{"key":"2021_CR31","doi-asserted-by":"crossref","unstructured":"Ainsua-Enrich E, Pedre\u00f1\u00f1o-Lopez N, Bracke C, et al. Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals. IScience. 2022:25.","DOI":"10.21203\/rs.3.rs-1551351\/v1"},{"key":"2021_CR32","first-page":"2150","volume":"118","author":"MA Berkowska","year":"2011","unstructured":"Berkowska MA, Driessen GJA, Bikos V, et al. Human memory B cells originate from three distinct germinal center-dependent and-independent maturation pathways. Blood J Am Soc Hematol. 2011;118:2150\u20138.","journal-title":"Blood J Am Soc Hematol"},{"key":"2021_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.hlife.2024.09.002","volume":"2","author":"C Guo","year":"2024","unstructured":"Guo C, Chai X, Baerlike M, et al. Comparison of antigen-specific B cell responses reveals disparity inimmunogenicity and memory B cell formation across COVID-19 vaccine platforms. HLife. 2024;2:625\u201340.","journal-title":"HLife"},{"key":"2021_CR34","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13083","volume":"10","author":"MZ Salleh","year":"2022","unstructured":"Salleh MZ, Norazmi MN, Deris ZZ. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2. PeerJ. 2022;10:e13083.","journal-title":"PeerJ"},{"key":"2021_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jinf.2023.06.022","volume":"87","author":"C Taucher","year":"2023","unstructured":"Taucher C, Lazarus R, Dellago H, et al. Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial. J Infect. 2023;87:242\u201354.","journal-title":"J Infect"},{"key":"2021_CR36","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41586-024-07539-1","volume":"630","author":"C-Y Liang","year":"2024","unstructured":"Liang C-Y, Raju S, Liu Z, et al. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines. Nature. 2024;630:950\u201360.","journal-title":"Nature"},{"key":"2021_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.immuni.2024.02.016","volume":"57","author":"MA Tortorici","year":"2024","unstructured":"Tortorici MA, Addetia A, Seo AJ, et al. Persistent immune imprinting occurs after vaccination with the COVID-19 XBB. 1.5 mRNA booster in humans. Immunity. 2024;57:904\u201311.","journal-title":"Immunity"},{"issue":"5","key":"2021_CR38","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41591-024-02962-3","volume":"30","author":"KAYH ZhongY","year":"2024","unstructured":"ZhongY KAYH, Tay CJX, et al. Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children. Nat Med. 2024;30(5):1373\u201383. Available at: https:\/\/www.nature.com\/articles\/s41591-024-02962-3","journal-title":"Nat Med"},{"key":"2021_CR39","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.jaci.2023.12.011","volume":"153","author":"OM Delmonte","year":"2024","unstructured":"Delmonte OM, OguzC DK, et al. Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immuno compromised individuals. J Allergy Clin Immunol. 2024;153:1655\u201367.","journal-title":"J Allergy Clin Immunol"},{"key":"2021_CR40","first-page":"244","volume":"20","author":"N Rezaei","year":"2010","unstructured":"Rezaei N, Aghamohammadi A, Nourizadeh M, et al. Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2010;20:244\u201351.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2021_CR41","first-page":"374","volume":"2021","author":"RR Goel","year":"1979","unstructured":"Goel RR, Painter MM, Apostolidis SA, et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science. 1979;2021:374.","journal-title":"Science"},{"key":"2021_CR42","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10875-021-01133-0","volume":"41","author":"AF Salinas","year":"2021","unstructured":"Salinas AF, Mortari EP, Terreri S, et al. SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best. J Clin Immunol. 2021;41:1709\u201322.","journal-title":"J Clin Immunol"},{"key":"2021_CR43","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/v13101945","volume":"13","author":"M Tutukina","year":"2021","unstructured":"Tutukina M, Kaznadzey A, Kireeva M, Mazo I. IgG antibodies develop to spike but not to the nucleocapsid viral protein in many asymptomatic and light COVID-19 cases. Viruses. 2021;13:1945.","journal-title":"Viruses"},{"issue":"8","key":"2021_CR44","doi-asserted-by":"publisher","first-page":"e2227348\u2013e","DOI":"10.1001\/jamanetworkopen.2022.27348","volume":"5","author":"RA Karron","year":"2022","unstructured":"Karron RA, Hetrich MK, Na YB, et al. Assessment of clinical and virological characteristics of SARS-CoV-2 infection among children aged 0 to 4 years and their household members. JAMA Network Open. 2022;5(8):e2227348\u2013e.","journal-title":"JAMA Network Open."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02021-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:35:08Z","timestamp":1782084908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02021-1","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KAT and HD received grants from the Coalition for Epidemic Preparedness Innovations outside the submitted work. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Moderna, Pfizer and Sanofi-Pasteur. All funds have been paid to his institute, and he has not received any personal payments. JC has received consultation, speaker fees, and educational funding not related to this study from Takeda, CSL Behring, Grifols, and Octapharma, GSK, Pfizer, Astrazeneca, EMD Serono, and Avir Pharma. LMF is a member of the Data Safety Monitoring Committee for Encoded Therapeutics and has participated as an Advisory Board Member for Takeda, both unrelated to the submitted work. BD is a member of a Data Safety Monitoring Committee and has participated as an Advisory Board Member for Takeda, not related to this study. APH has received educational funding not related to this study from CSL Behring. The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript: LLTNP, DY, DU, ELF, HC, DV, TI, JU, BS, TR, SS, NW, TK, LB, SO, MAL, CA, TZ, TR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"68"}}